Literature DB >> 17036434

The problem with optimism in clinical trials.

Lynn A Jansen1.   

Abstract

Keywords:  Analytical Approach; Biomedical and Behavioral Research

Mesh：

Year:  2006        PMID： 17036434

Source DB:  PubMed          Journal:  IRB        ISSN： 0193-7758


× No keyword cloud information.
  17 in total

1.  Marginalized populations and drug addiction research: realism, mistrust, and misconception.

Authors:  Celia B Fisher; Matthew Oransky; Meena Mahadevan; Merrill Singer; Greg Mirhej; Derrick Hodge
Journal:  IRB       Date:  2008 May-Jun

2.  An approach to evaluating the therapeutic misconception.

Authors:  Scott Y H Kim; Lauren Schrock; Renee M Wilson; Samuel A Frank; Robert G Holloway; Karl Kieburtz; Raymond G de Vries
Journal:  IRB       Date:  2009 Sep-Oct

3.  Motivations and Decision Making Processes of Men With X-linked Retinoschisis Considering Participation in an Ocular Gene Therapy Trial.

Authors:  Amy Turriff; Delphine Blain; Morgan Similuk; Barbara Biesecker; Henry Wiley; Catherine Cukras; Paul A Sieving
Journal:  Am J Ophthalmol       Date:  2019-03-16       Impact factor: 5.258

4.  Is payment a benefit?

Authors:  Alan Wertheimer
Journal:  Bioethics       Date:  2011-07-04       Impact factor: 1.898

5.  Hope for health and health care.

Authors:  William E Stempsey
Journal:  Med Health Care Philos       Date:  2015-02

6.  Therapeutic misconception, misestimation, and optimism in participants enrolled in phase 1 trials.

Authors:  Rebecca D Pentz; Margaret White; R Donald Harvey; Zachary Luke Farmer; Yuan Liu; Colleen Lewis; Olga Dashevskaya; Taofeek Owonikoko; Fadlo R Khuri
Journal:  Cancer       Date:  2012-01-31       Impact factor: 6.860

7.  Unrealistic optimism in early-phase oncology trials.

Authors:  Lynn A Jansen; Paul S Appelbaum; William M P Klein; Neil D Weinstein; William Cook; Jessica S Fogel; Daniel P Sulmasy
Journal:  IRB       Date:  2011 Jan-Feb

8.  The culture of faith and hope: patients' justifications for their high estimations of expected therapeutic benefit when enrolling in early phase oncology trials.

Authors:  Daniel P Sulmasy; Alan B Astrow; M Kai He; Damon M Seils; Neal J Meropol; Ellyn Micco; Kevin P Weinfurt
Journal:  Cancer       Date:  2010-08-01       Impact factor: 6.860

9.  Research participants' high expectations of benefit in early-phase oncology trials: are we asking the right question?

Authors:  Kevin P Weinfurt; Damon M Seils; Li Lin; Daniel P Sulmasy; Alan B Astrow; Herbert I Hurwitz; Roger B Cohen; Neal J Meropol
Journal:  J Clin Oncol       Date:  2012-10-22       Impact factor: 44.544

10.  Participants' Perceptions of Deep Brain Stimulation Research for Treatment-Resistant Depression: Risks, Benefits, and Therapeutic Misconception.

Authors:  Yan Leykin; Paul P Christopher; Paul E Holtzheimer; Paul S Appelbaum; Helen S Mayberg; Sarah H Lisanby; Laura B Dunn
Journal:  AJOB Prim Res       Date:  2011-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.